CYP2U1-AS1 (Gene)

Entrez:101929595

Description:CYP2U1 and SGMS2 antisense RNA 1

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CYP2U1-AS1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CYP2U1-AS1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CYP2U1-AS1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CYP2U1-AS1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP2U1-AS1.

Results found

Linked to

	Label	Description
	GSE128885 deferiprone macrophage 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115550 BRD4 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE121425 GSE121426 LSD1 inhibition SET-2 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203267 ALKBH5 knockdown Ramia 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE223313 naringenin 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE219274 GSE219276 doxorubicin Hs 578T 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150244 TRIM8 knockout 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE115550 BRD4 inhibition 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE121425 GSE121426 LSD1 inhibition SET-2 2 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE203267 ALKBH5 knockdown Ramia 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE223313 naringenin 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE219274 GSE219276 doxorubicin Hs 578T 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE150244 TRIM8 knockout 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.